कंपनी का अवलोकन
Natural Alternatives International, Inc. (NAII) is primarily engaged in the formulation, manufacturing, and marketing of nutritional supplements within the United States and international markets. The corporation operates through two distinct business segments: Private-Label Contract Manufacturing and Patent and Trademark Licensing, allowing it to serve both contract clients and its own branded products. This entity functions within the Consumer Defensive sector, specifically under the Packaged Foods industry, which generally implies a business model focused on providing essential goods that are less sensitive to economic downturns compared to discretionary spending categories. With a total market capitalization of $16.92M and annual revenue of $135.16M, the company supports a workforce of 293 employees. The relatively modest market cap figure, combined with the substantial revenue base exceeding one hundred million dollars, indicates that the company holds a niche position in the market rather than being a dominant market leader, suggesting a specialized operational focus within the nutritional supplement supply chain.
वित्तीय स्वास्थ्य
The company reported a trailing twelve-month revenue of $135.16M, yet it simultaneously recorded a net income loss of -$12,246,000 and an EBITDA of $424,000. The significant negative gap between the positive revenue figure and the substantial net loss reveals a cost structure where operating expenses, including the cost of goods sold and administrative costs, far exceed the earnings generated before interest and taxes. While the EBITDA remains positive at $424,000, the free cash flow stands at only $108,500, indicating that the company generates very limited cash flow from operations after capital expenditures and working capital changes, which restricts its financial flexibility for expansion or debt repayment. The gross margin is recorded at 9.1%, suggesting that the cost of producing these nutritional supplements consumes the vast majority of the sales revenue. Furthermore, the operating margin is -5.3% and the profit margin is -9.1%, indicating that the company is currently operating at a loss on a per-unit basis after accounting for all operational inefficiencies and overhead costs. On the liability side, the company holds $3.75M in cash against $61.71M in debt, resulting in a debt-to-equity ratio of 92.04, which signifies a highly leveraged balance sheet where debt obligations significantly outweigh equity capitalization. Despite this leverage, the current ratio is 1.87, indicating that the company possesses sufficient current assets relative to its current liabilities to meet its short-term obligations without immediate distress. Finally, the return on equity is -16.8% and the return on assets is -1.7%, revealing that management has been ineffective in generating positive returns on the shareholders' capital and the company's asset base during the trailing period.
मूल्यांकन आकलन
The trailing P/E ratio is listed as N/A, and the forward P/E is also N/A, which implies that traditional earnings-based valuation multiples cannot be applied due to the company's current lack of profitability and negative net income figures. The price-to-book ratio is 0.25, indicating that the market is valuing the company at a significant discount to its net asset book value, often seen in distressed or turnaround situations where intangible assets are undervalued on the balance sheet. In addition to the P/B metric, the price-to-sales ratio is 0.13 and the EV/EBITDA stands at 175.48, suggesting that the market places a very low premium on the company's sales revenue relative to its enterprise value while acknowledging the high earnings multiple driven by the current earnings deficit. The stock has traded within a 52-week high of $4.96 and a 52-week low of $2.33, meaning the current trading price sits in the lower portion of this historical range, reflecting the market's cautious stance on the company's financial prospects. The beta value is 0.39, which indicates that the stock price exhibits significantly lower volatility relative to the broader market, moving less than half as much as the overall index during periods of market fluctuation.
Growth & Income
The revenue growth year-over-year is 2.1%, whereas the earnings growth is N/A, highlighting that while the top line is expanding slightly, the earnings base remains negative and unable to sustain a growth rate comparable to the revenue expansion. Since the company has no dividend yield and a payout ratio of 0.0%, it does not distribute cash to shareholders, which necessitates that all earnings or retained cash be reinvested into the business operations or used to service its significant debt obligations rather than providing income to investors. The absence of a dividend payout further underscores the company's current priority on financial survival and debt management given the negative net income and high leverage ratio. Overall, the growth and income profile presents a scenario of modest revenue expansion coupled with an absence of earnings growth and no dividend distribution, painting a picture of a company in a developmental or restructuring phase rather than a mature income-generating entity.